United Drug to buy JVA for up to €21m

DUBLIN-BASED international drug wholesale group United Drug has completed its seventh acquisition of the year by buying Irish company JVA Analytical for an initial consideration of €16.5 million in cash.

United Drug will pay an additional €4.5m for JVA depending on certain agreed performance targets being met over the next two years. The latest acquisition will act as a bolt-on to United Drug’s medical and scientific division and will broaden the range of customers to whom it provides support and services.

Commenting on the deal, United Drug chief executive Liam FitzGerald said: “(JVA) has a long established reputation as a high quality provider of equipment and services to the analytical chemistry sector in Ireland. It will form an important part of our medical and scientific division.”